RNAi2012 invites demonstration of general molecular and cellular biology products related to RNA research, and commercial sponsorship. You are invited to choose from a variety of highly-competitive sponsorship packages listed below. If your needs are not covered by the offered packages please contact us in the first instance and we shall do our best to develop a package to suit your requirements.
- Gold: Includes a speaker slot AND an exhibition stand (max 3)
- Silver: Includes a speaker slot OR an exhibition stand (max 3)
- Keynote Speakers
- Podium Sessions
- Lunch/Dinner
- Refreshment Breaks
- Drinks Reception
- Delegate Bags (max 2)
- Delegate Badges (max 2)
- Conference Proceedings (max 2)
To increase interaction with delegates, refreshments will be held in the main exhibition area. Spaces for exhibitions are limited and are allocated on a first-come-first-served basis. To get a location of choice, and to avail our special promotional offers we srtrongly recommend an early booking.
Exhibition package includes the following benefits:
- Admittance for TWO exhibitors (includes lunches and refreshments)
- Approximately 7 (w) x 4 (d) feet exhibition area (with 5 x 2 feet table top and two chairs)
- On site parking for one car for the duration of the conference
- Free access to combined, multiple use delegate emailing list (available after the conference)
- Free weblink to one preferred website on multiple pages
- Brief company profile (~250 words) on the conference website
- Brief company profile (~250 words) in the conference handbook
- Invitation to submit a poster abstract
For a Booking Form and further information about packages and other promotional opportunities please contact Dr Muhammad Sohail by email on RNAiOxford@gmail.com.
Terms & Conditions of Booking
RNAi2012 Sponsors
Gold Sponsor and Exhibitor
Molecular Devices provides a full line of imaging products to support your high-content analysis needs. Whether you are working with stem cells or seeking to observe the gene silencing effects of RNAi, the ImageXpress® Micro System helps you decipher the complex cellular and molecular events that underlie cell division and differentiation or changes in morphology, development and behaviour in your sample.
This High-Content Screening microscope can therefore be an invaluable tool for pinpointing mechanisms of action in the research or treatment of cancer, neurological disorders, viral infection, hemophilia, and premature aging. Regardless of resolution, and thanks to its laser auto focusing capabilities, brightfield imaging option and environmentally controlled chamber, the ImageXpress® Micro XL System offers researchers the benefit of imaging three times the sample area to deliver statistically relevant results in a third of the time. Whether you are searching for rare events or investigating multifaceted cell signaling pathways, the ImageXpress Micro XL offers three times the data points per image to decrease your time to perform cellular- and high-resolution screens. This easily enables users to measure parameters such as cell cycle and apoptosis, the formation of micronuclei, neurite outgrowth, angiogenesis, intracellular translocation or endocytosis. For each assay, biological phenotypes can be automatically identified, segmented, and analyzed using a validated software module to generate accurate results for rapid screening.
Gold Sponsor and Exhibitor
Sigma-Aldrich is a global supplier of leading RNA interference (RNAi) tools including siRNA and the comprehensive MISSION™ shRNA library through participation in The RNAi Consortium (TRC). As a key licensed supplier of siRNA and expert in high quality custom DNA and RNA oligonucleotide synthesis, our goal is to provide innovative products to meet your functional genomics and gene silencing research needs. The MISSION shRNA library of The RNAi Consortium, developed by the Broad Institute of MIT and Harvard, is a pre-cloned collection targeted against annotated human and mouse genes enabling scientists to elucidate gene function. For further details of the above products please visit www.sigma-aldrich.com/rnai.
Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 35 countries and has over 6,800 employees providing excellent service worldwide. We are committed to accelerating Customers’ success through leadership in Life Science, High Technology and Service.
Delegate Badge Sponsor
Cenix BioScience GmbH is a contract research organization specialized in combining advanced applications of RNAi screening with high-content phenotypic analyses. Cenix has built up a dominant track record in this field, successfully advancing therapeutic programs for numerous industry and academic partners by providing fully customized, cutting-edge research offerings covering a wide range of disease fields including oncology, cardiovascular, metabolic, neurological and infectious diseases. The well-established core capabilities in high-throughput siRNA screening and multi-parametric microscopy assays have yielded optimized protocols in a broad and ever-growing collection of cultured cell models, and are now complemented by miRNA screening, and in vivo RNAi applications using synthetic siRNAs. As such, Cenix is a mature and fully proven industrial research provider, applying the highest of scientific best practices and offering a breadth and depth of specialist expertise second to none worldwide.
Exhibitor
Eupheria Biotech GmbH: Our mission is dedication to our customer's research needs delivering high quality RNAi products combined with aligned services. We develop and produce RNAi reagents using cutting-edge technology, such as endoribonuclease prepared siRNAs (esiRNAs). Our company is continously aiming for innovations to provide the most efficient silencing triggers available in the market with substantially less off-target effects guaranteeing best results for our customers.
Our RNAi products provide RNAi researchers with a proven, cost effective and simple way to perform experiments, from single gene knockdown to genom-wide screens. Our enzymatically prepared, multiple silencing triggers lead to highly specific and effective gene silencing. We have just launched a brand new library of esiRNAs targeting long non-coding transcripts from the Mus Musculus genome in addition to the first commercially available library of RNAi mediators for Tribolium Castaneum.
Exhibitor
Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the United States. Serving the areas of academic research, biotechnology, clinical diagnostics and pharmaceutical development, IDT’s primary business is the manufacturing of DNA and RNA oligonucleotides (oligos) for research applications. Basic product offerings include DNA oligos, RNA oligos, and over one hundred chemical modifications, ranging from short single-stranded oligos to 10,000 base pair synthetic genes. IDT products support DNA sequencing, DNA amplification, SNP detection, microarray analysis, expression profiling, gene quantification, and functional genomics.
IDT’s Dicector™ line, the latest innovation in RNA research, combines a proven commitment to quality with Dicer-substrate technology to provide researchers with tools for RNAi research. Among the offerings is the TriFECTa™ Kit, recently improved to provide guaranteed knockdown for 2 of 3 duplexes.
IDT’s microCache™ line, a group of small RNA cloning products, is highlighted by the miRCat™ small RNA cloning kit, which permits cloning from any RNA source in any species. Additional products include 3' and 5' cloning linkers, internal RNA controls, and 454 adapter primer sets.
In addition to its corporate headquarters in Coralville, Iowa, IDT has production centers in San Diego, California and Leuven, Belgium.
Exhibitor
Exiqon - microRNA products and services: Exiqon offers microRNA products and services based on our proprietary LNA™ technology. Unlike DNA or RNA oligos, LNA™-enhanced primers and probes can be used to reliably detect short target sequences, making them ideal for microRNA research.
Exiqon’s miRCURY LNA™ product line covers the entire microRNA research process, from RNA isolation to functional analysis:
- miRCURY™ RNA Isolation Kit – Fast and easy total RNA extraction from a wide range of sample sources.
- miRCURY LNA™ microRNA Arrays – Highly sensitive and specific microRNA microarray expression profiling. LNA™-enhanced capture probes for detection of ALL microRNAs, including AU-rich sequences. Use our Hi-Power labeling kits for DOUBLE signal intensities.
- miRCURY LNA™ Universal RT microRNA PCR – Extremely sensitive and specific LNA™-enhanced qPCR system. Available in 96- and 384-well format and as pre-designed or custom-made individual assays. Profile 750 microRNAs using 40 ng total RNA in just 3 hours. Use Exiqon’s SYBR® Green master mix and cDNA synthesis kits for optimal performance.
- miRCURY LNA™ microRNA Detection Probes – Pre-designed LNA™-enhanced probes for in situ hybridization and Northern blot analysis. Available with a wide range of modifications and labels. Buffer and optimization kit also available.
- miRCURY LNA™ microRNA Inhibitors – Highly potent LNA™-enhanced microRNA inhibitors available for in vitro and in vivo silencing of microRNAs. Inhibitor libraries in 96-well format also available.
Exiqon also offers microRNA services. Let us prepare your RNA and perform your PCR or microarray microRNA experiments. We offer everything from an initial consultation to the final data analysis.
Learn more at www.exiqon.com
Drinks
RiboBio is a privately held company with the initial focus on development and commercialization of oligonucleotide-based reagents and services. The company employs >60 people, with ~70% of the employees working in R&D. In addition to RiboBio’s current facilities, the new 2,500 m2 space has been recently renovated and will accommodate a GMP synthesis pilot plant, a high-throughput oligo synthesis equipment and a high-throughput and high-content screening facility. The latter will be set up as part of the RNAi Drug Discovery Center. Argo Pharma, a company fully owned by RiboBio, was founded in 2010 to develop oligonucleotide-based and other therapeutics. The two companies have plans to complete pre-clinical research for at least two drug candidates and to file two INDs in China in 2012-13. RiboBio’s long-term goal is to establish itself as a global player in the research tool market, develop partnerships and collaborations with large companies and, through its Argo Pharma arm, become a leading therapeutic company in China.
Sponsoring Publication
Journal of RNAi and Gene Silencing - an open access publication - will publish high-quality, peer-reviewed articles addressing most aspects of small RNA biology and application in biotechnology and therapy.
Gold Sponsor and Exhibitor
Molecular Devices provides a full line of imaging products to support your high-content analysis needs. Whether you are working with stem cells or seeking to observe the gene silencing effects of RNAi, the ImageXpress® Micro System helps you decipher the complex cellular and molecular events that underlie cell division and differentiation or changes in morphology, development and behaviour in your sample. This High-Content Screening microscope can therefore be an invaluable tool for pinpointing mechanisms of action in the research or treatment of cancer, neurological disorders, viral infection, hemophilia, and premature aging. Regardless of resolution, and thanks to its laser auto focusing capabilities, brightfield imaging option and environmentally controlled chamber, the ImageXpress® Micro Widefield Imaging System easily enables users to measure parameters such as cell cycle and apoptosis, the formation of micronuclei, neurite outgrowth, angiogenesis, intracellular translocation or endocytosis. For each assay, biological phenotypes can be automatically identified, segmented, and analyzed using a validated software module to generate accurate results for rapid screening.
Gold Sponsor and Exhibitor
Sigma-Aldrich is a global supplier of leading RNA interference (RNAi) tools including siRNA and the comprehensive MISSION™ shRNA library through participation in The RNAi Consortium (TRC). As a key licensed supplier of siRNA and expert in high quality custom DNA and RNA oligonucleotide synthesis, our goal is to provide innovative products to meet your functional genomics and gene silencing research needs. The MISSION shRNA library of The RNAi Consortium, developed by the Broad Institute of MIT and Harvard, is a pre-cloned collection targeted against annotated human and mouse genes enabling scientists to elucidate gene function. For further details of the above products please visit www.sigma-aldrich.com/rnai.
Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 35 countries and has over 6,800 employees providing excellent service worldwide. We are committed to accelerating Customers’ success through leadership in Life Science, High Technology and Service.
Drinks Reception/Posters Sponsor
Thermo Scientific is the world's leading brand of innovative Dharmacon RNA interference research products. We supply the highest quality custom RNA oligonucleotides and siRNA, as well as siRNA transfection reagents and innovative ready-to-use SMARTvector™ Lentiviral shRNA Particles. Thermo Scientific offers guaranteed pre-designed Dharmacon siRNA reagents targeting all unique human, mouse, and rat genes in the NCBI RefSeq database. These genome-wide reagents include the market-leading ON-TARGETplus™ siRNA, proven to reduce off-targets by up to 90%. In addition to our groundbreaking research tools, we now provide RNAi library screening and microRNA expression analysis services.
ABgene ® – now sold as Thermo Scientific - manufactures and develops high-performance QPCR reagents and amplification plastics that facilitate reproducible, sensitive and accurate quantization of all nucleic acid targets. Through constant customer feedback and an innovative approach to product development, Thermo Scientific has developed a portfolio of industry-leading products.
Delegate Badge Sponsor
Cenix BioScience GmbH is a contract research organization (CRO) specialized in combining advanced applications of RNAi with high content phenotypic analyses. In meanwhile over 11 years, Cenix has built up a dominant track record in this field, successfully advancing therapeutic programs for numerous major industry and academic partners by providing fully customized, cutting-edge research offerings covering a wide range of disease fields including oncology, cardiovascular, metabolic, neurological and infectious diseases. The well-established core capabilities in high throughput siRNA screening and multi-parametric microscopy assays have yielded optimized protocols in a broad and ever-growing collection of cultured cell models, and are now complemented by miRNA screening, and in vivo RNAi applications using synthetic siRNAs. As such, Cenix is a mature and fully proven industrial research provider, applying the highest of scientific best practices and offering a breadth and depth of specialist expertise second to none worldwide. For more details, visit http://www.cenix.com.
Exhibitor
Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide. In addition to publishing over 4,600 new books each year. Oxford Journals, a Division of Oxford University Press, publishes well over 220 journals, two-thirds of which are published in collaboration with learned societies and other international organizations
Wine Sponsor
RXi Pharmaceuticals is a leader in Next Generation RNA targeting, including its proprietary rxRNA™ discovery platform and delivery technologies, for the treatment of human diseases. RXi is a biopharmaceutical company engaged in the discovery, development and commercialization of proprietary therapeutics based on RNA interference (RNAi). RXi Pharmaceuticals believes it is well positioned to compete successfully in the RNAi therapeutics market with its strong technology platform, broad and early intellectual property position, a management team that is experienced in commercializing products, and accomplished scientific advisors, including Dr. Craig Mello, recipient of the 2006 Nobel Prize for his co-discovery of RNAi.
Sponsoring Publication
Media Partner
